View Information Collection Request (ICR) Package
Skip to main content
An official website of the United States government
The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Search:
Agenda
Reg Review
ICR
This script is used to control the display of information in this page.
Display additional information by clicking on the following:
All
Brief and OIRA conclusion
Abstract/Justification
Legal Statutes
Rulemaking
FR Notices/Comments
IC List
Burden
Misc.
Common Form Info.
Certification
View Information Collection (IC) List
View Supporting Statement and Other Documents
Please note that the OMB number and expiration date may not have been determined when this Information Collection Request and associated Information Collection forms were submitted to OMB. The approved OMB number and expiration date may be found by clicking on the Notice of Action link below.
View Generic ICR - OIRA Conclusion
OMB Control No:
0938-1188
ICR Reference No:
202404-0938-022
Status:
Active
Previous ICR Reference No:
202307-0938-010
Agency/Subagency:
HHS/CMS
Agency Tracking No:
CMCS
Title:
Medicaid and CHIP Program (MACPro) (CMS-10434)
Type of Information Collection:
Revision of a currently approved collection
Common Form ICR:
No
Type of Review Request:
Regular
OIRA Conclusion Action:
Approved without change
Conclusion Date:
07/05/2024
Retrieve Notice of Action (NOA)
Date Received in OIRA:
05/02/2024
Terms of Clearance:
OMB is approving this information collection request for a period of three years during which time the agency will request approval to extend or revise the collection if the agency seeks to continue the information collection activity beyond the period approved under this action.
Inventory as of this Action
Requested
Previously Approved
Expiration Date
07/31/2027
36 Months From Approved
09/30/2026
Responses
1,029
0
716
Time Burden (Hours)
221,839
0
96,844
Cost Burden (Dollars)
0
0
0
Abstract:
CMS is in the process of evaluating Medicaid systems currently operating, in order to build an enterprise architecture platform and data repository. Ideally, CMS would allow for a single point of entry to access various program and operational data applications. This effort will be implemented in phases over several years. Phase 1 will provide for a Medicaid and CHIP Program data system (MACPro) accessed through a web portal/portlet that will automate the input and retrieval of data from the states related to CHIP eligibility and Alternative Benchmark Plans (ABP). This system will also support an efficient workflow for the review and approval of the CHIP and ABP process. States will access this system and submit program information into structured data templates. CMS staff will review the templates for compliance with federal statute, regulation and policy, provide feedback to the states and track/monitor the review and approval process. Future project phasing will provide for the design, delivery and implementation of financial management programs and performance and quality metrics. CMS must meet a hard deadline for the implementation of the Affordable Care Act. This system will be operational in phases with the CHIP eligibility and benchmark plans portions/modules to be implemented in January 2013.
Authorizing Statute(s):
PL:
Pub.L. 111 - 148 1103
Name of Law: Patient Protection and Affordable Care Act
Citations for New Statutory Requirements:
PL: Pub.L. 111 - 148 1103 Name of Law: Patient Protection and Affordable Care Act
Associated Rulemaking Information
RIN:
Stage of Rulemaking:
Federal Register Citation:
Date:
Not associated with rulemaking
Federal Register Notices & Comments
60-day Notice:
Federal Register Citation:
Citation Date:
89 FR 7720
02/05/2024
30-day Notice:
Federal Register Citation:
Citation Date:
89 FR 30377
04/23/2024
Did the Agency receive public comments on this ICR?
Yes
Number of Information Collection (IC) in this ICR:
10
IC Title
Form No.
Form Name
GenIC #26 (Revision): Child and Adult Core Set Measures
AQM-10, AQM-24, AQM-01, AQM-02, AQM-03, AQM-04, AQM-05, AQM-06, AQM-07, AQM-08, AQM-09, AQM-11, AQM-12, AQM-13 PQI 01, AQM-14 PQI 05, AQM-15 PQI 15, AQM-16 PQI 08, AQM-17, AQM-18, AQM-19, AQM-20, AQM-21, AQM-22, AQM-23, AQM-25, AQM-26, AQM-27, AQM-28, AQM-29, AQM-30, AQM-36, AQM-35, AQM-31, AQM-32, AQM-33, AQM-34, AQM-37, AQM-38, AQM-39, AQM-40, CQM-01, CQM-02, CQM-03, CQM-04, CQM-05, CQM-06, CQM-07, CQM-08, CQM-09, CQM-10, CQM-11, CQM-12, CQM-13, CQM-14, CQM-15, CQM-16, CQM-17, CQM-18, CQM-19, CQM-20, CQM-21, CQM-22, CQM-23, CQM-25, CQM-26, CQM-27, CQM-28, CQM-29, CQM-30, SQM-01, CQM-24
Cervical Cancer Screening
,
Chlamydia Screening in Women Ages 21-24
,
Colorectal Cancer Screening
,
Long-Term Services and Supports Comprehensive Care Plan and Update
,
Screening for Depression and Follow-Up Plan: Age 18 and older
,
Breast Cancer Screening
,
Prenatal and Postpartum Care: Ages 21 and older
,
Contraceptive Care Postpartum Women Ages 21-44
,
Contraceptive Care - All Women Ages 21 to 44
,
Controlling High Blood Pressure
,
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis
,
Glycemic Status Assessment for Patients with Diabetes
,
Diabetes Short-term Complications Admission Rate
,
Chronic Obstructive Pulmonary Disease (COPD) or Asthma in Older Adults Admission Rate
,
Asthma in Younger Adults Admission Rate
,
Heart Failure Admission Rate
,
Plan All-Cause Readmissions
,
Asthma Medication Ratio: Ages 19 to 64
,
HIV Viral Loan Suppression
,
Initiation and Engagement of Substance Use Disorder Treatment
,
Medical Assistance with Smoking and Tobacco Use Cessation
,
Antidepressant Medication Management
,
Follow-up after Hospitalization for Mental Illness: Age 18 and older
,
Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications
,
Diabetes Care for People with Serious Mental Illness: Hemoglobin A1C (HbA1c) Poor Control (>9.0%)
,
Use of Opioids at High Dosage in Persons Without Cancer
,
Concurrent Use of Opioids and Benzodiazepines
,
Use of Pharmacotherapy for Opioid Use Disorder
,
Follow-up After Emergency Department Visit for Substance Use: Age 18 and Older
,
Follow-Up after Emergency Department Visit for Mental Illness: Age 18 and Older
,
Adherence to Antipsychotic Medications for Individuals with Schizophrenia
,
Consumer Assessment of Healthcare Providers and Systems (CAHPS) Health Plan Survey 5.10H, Adult Version (Medicaid)
,
National Core Indicators
,
Adult Immunization Status
,
Ambulatory Care Sensitive Emergency Department Visits for Non-Traumatic Dental Conditions in Adults
,
Low-Risk Cesarean Deliver: Age 20 and Older
,
Oral Evaluation During Pregnancy: Ages 21 to 44
,
Postpartum Depression Screening and Follow-Up: Age 21 and Older
,
Prenatal Immunization Status: Age 21 and Older
,
Adult Core Set Common Questions
,
Weight Assessment and Counseling for Nutrition and Physical Activity for Children/Adolescents
,
Chlamydia Screening in Women Ages 21-24
,
Childhood Immunization Status
,
Screening for Depression and Follow-up Plan: Ages 12 to 17
,
Well-Child Visits in the First 30 Months of Life
,
Immunizations for Adolescents
,
Developmental Screening in the First Three Years of Life
,
Child and Adolescent Well-Care Visits
,
Live Births Weighing Less Than 2,500 Grams
,
Prenatal and Postpartum Care: Under Age 21
,
Contraceptive Care - Postpartum Women Ages 15 to 20
,
Contraceptive Care - All Women Ages 15 to 20
,
Low-Risk Cesarean Delivery
,
Asthma Medication Ratio: Ages 5 to 18
,
Follow-Up Care for Children Prescribed Attention-Deficit/Hyperactivity Disorder (ADHD) Medication
,
Follow-Up After Hospitalization for Mental Illness: Ages 6 to 17
,
Metabolic Monitoring for Children and Adolescents on Antipsychotics
,
Use of First-Line Psychosocial Care for Children and Adolescents on Antipsychotics
,
Follow-Up After Emergency Department Visit for Substance Use: Ages 13 to 17
,
Follow-Up After Emergency Department Visit for Mental Illness: Ages 6 to 17
,
Oral Evaluation, Dental Services
,
Topical Fluoride for Children
,
Sealant Receipt on Permanent First Molars
,
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis: Age 3 months to 17 years
,
Lead Screening in Children
,
Oral Evaluation During Pregnancy: Ages 15 to 20
,
Postpartum Depression Screening and Follow-Up: Under Age 21
,
Prenatal Immunization Status: Under Age 21
,
Child Common Questions (No changes)
,
Stratification Common Questions (Revised)
,
Consumer Assessment of Healthcare Providers and Systems (CAHPS) Health Plan Survey 5.1H - Child Version Including Medicaid and Children with Chronic Conditions Supplemental Items
GenIC #47 (Revised):Health Home Core Sets
HHQM-01, HHQM-02, HHQM-03, HHQM-04, HHQM-05, HHQM-06, HHQM-07, HHQM-08, HHQM-09, HHQM-11, HHQM-14, HHQM-15, HHQM-15, HHQM-13
Initiation and Engagement of Alcohol and Other Drug Abuse or Dependence Treatment
,
Controlling High Blood Pressure
,
Colorectal Cancer Screening
,
Screening for Depression and Follow-Up Plan
,
Follow-Up after Hospitalization for Mental Illness
,
Plan All-Cause Readmissions
,
Use of Pharmacotherapy for Opioid Use Disorder
,
Follow-Up after Emergency Department for Alcohol and Other Drug Abuse or Dependence
,
Follow-Up After Emergency Department Visit for Mental Illness: Age 6 and Older
,
Admission to an Institution from the Community
,
Common Questions
,
Stratification Common Questions - 1997 Office of Management and Budget (OMB) minimum race and ethnicity categories
,
Stratification Common Questions - Statistical Policy Directive #15: 2024 OMB race and ethnicity standards
,
Inpatient Utilization
GenIC #66 (Revision): Eligibility Processing Data Report and Renewal Compliance Template
CMS-10398 #66, CMS-10398 #66, CMS-10398 #66
Compliance Assessment and Plan for Federal Medicaid and CHIP Renewal Requirements Template
,
Eligibility Processing Data Report (portal)
,
Eligibility Processing Data Report (Excel workbook)
GenIC #66 (Revision): Medicaid and Children's Health Insurance Program Eligibility Processing Data Report
CMS-10398 #66, CMS-10398 #66
Eligibility Processing Data Report portal screen shots
,
Eligibility Processing Data Report excel workbook
Used Burden (GenIC Inventory)
[Medicaid] GenIC #26 (Nonsubstantive Change): Child and Adult Core Set Measures
[Medicaid] GenIC #26 (Revised): Child and Adult Core Set Measures
CQM-18, CQM-19, CQM-20, CQM-21, CQM-22, CQM-23, CQM-24, CQM-25, CQM-26, CQM-27, CQM-28, CMS-10434 #26, AQM-01, AQM-02, QM-04, AQM-03, AQM-05, AQM-06, AQM-07, AQM-08, AQM-09, AQM-10, AQM-11, AQM-12, AQM-14, PQI 05, AQM-13, PQI 01, AQM-14, PQI 05, AQM-15, PQI 15, AQM-16, PQI 08, AQM-17, AQM-18, AQM-19, AQM-20, AQM-21, AQM-30, CQM-02, CQM-03, CQM-04, CQM-05, CQM-06, CQM-07, CQM-08, CQM-12, CQM-09, CQM-10, CQM-11, CQM-13, CQM-14, CQM-15, CQM-16, AQM-22, AQM-23, AQM-24, AQM-25, AQM-26, AQM-27, AQM-28, AQM-29, AQM-31, AQM-32, AQM-33, AQM-34, CQM-01, CQM-17
Cervical Cancer Screening
,
Chlamydia Screening in Women Ages 21-24
,
Colorectal Cancer Screening
,
Long-Term Services and Supports Comprehensive Care Plan and Update
,
Screening for Depression and Follow-Up Plan: Age 18 and older
,
Breast Cancer Screening
,
Prenatal and Postpartum Care: Ages 21 and older
,
Contraceptive Care Postpartum Women Ages 21-44
,
Contraceptive Care - All Women Ages 21 to 44
,
Controlling High Blood Pressure
,
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis
,
Hemoglobin A1c Control for Patients with Diabetes (>9.0%)
,
Chronic Obstructive Pulmonary Disease (COPD) or Asthma in Older Adults Admission Rate
,
Diabetes Short-term Complications Admission Rate
,
Chronic Obstructive Pulmonary Disease (COPD) or Asthma in Older Adults Admission Rate
,
Asthma in Younger Adults Admission Rate
,
Heart Failure Admission Rate
,
Plan All-Cause Readmissions
,
Asthma Medication Ratio: Ages 19 to 64
,
HIV Viral Loan Suppression
,
Initiation and Engagement of Substance Use Disorder Treatment
,
Medical Assistance with Smoking and Tobacco Use Cessation
,
Antidepressant Medication Management
,
Follow-up after Hospitalization for Mental Illness: Age 18 and older
,
Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications
,
Diabetes Care for People with Serious Mental Illness: Hemoglobin A1C (HbA1c) Poor Control (>9.0%)
,
User of Opioids at High Dosage in Persons Without Cancer
,
Concurrent Use of Opioids and Benzodiazepines
,
Use of Pharmacotherapy for Opioid Use Disorder
,
Follow-up After Emergency Department Visit for Substance Use: Age 18 and Older
,
Follow-Up after Emergency Department Visit for Mental Illness: Age 18 and Older
,
Adherence to Antipsychotic Medications for Individuals with Schizophrenia
,
Consumer Assessment of Healthcare Providers and Systems (CAHPS) Health Plan Survey 5.10H, Adult Version (Medicaid)
,
National Core Indicators
,
Adult Common Questions
,
Weight Assessment and Counseling for Nutrition and Physical Activity for Children/Adolescents
,
Chlamydia Screening in Women Ages 21-24
,
Childhood Immunization Status
,
Screening for Depression and Follow-up Plan: Ages 12 to 17
,
Well-Child Visits in the First 30 Months of Life
,
Immunizations for Adolescents
,
Developmental Screening in the First Three Years of Life
,
Child and Adolescent Well-Care Visits
,
Live Births Weighing Less Than 2,500 Grams
,
Prenatal and Postpartum Care: Under Age 21
,
Contraceptive Care - Postpartum Women Ages 15 to 20
,
Contraceptive Care - All Women Ages 15 to 20
,
Low-Risk Cesarean Delivery
,
Asthma Medication Ratio: Ages 5 to 18
,
Ambulatory Care: Emergency Department (ED) Visits
,
Follow-Up Care for Children Prescribed Attention-Deficit/Hyperactivity Disorder (ADHD) Medication
,
Follow-Up After Hospitalization for Mental Illness: Ages 6 to 17
,
Metabolic Monitoring for Children and Adolescents on Antipsychotics
,
Use of First-Line Psychosocial Care for Children and Adolescents on Antipsychotics
,
Follow-Up After Emergency Department Visit for Substance Use: Ages 13 to 17
,
Follow-Up After Emergency Department Visit for Mental Illness: Ages 6 to 17
,
Oral Evaluation, Dental Services
,
Topical Fluoride for Children
,
Sealant Receipt on Permanent First Molars
,
Consumer Assessment of Healthcare Providers and Systems (CAHPS) Health Plan Survey 5.1H - Child Version Including Medicaid and Children with Chronic Conditions Supplemental Items
,
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis: Age 3 months to 17 years
,
Lead Screening in Children
,
Child Common Questions
,
Medicaid Eligibility SPA Template
[Medicaid] GenIC #47 (Revised): Health Home Core Sets
HHQM - 02, HHQM - 01, HHQM - 03, HHQM - 04, HHQM-05, HHQM - 06, HHQM - 07, HHQM - 08, HHQM - 09, HHQM - 11, HHQM - 12, HHQM - 14, HHQM - 10, HHQM - 13
Initiation and Engagement of Alcohol and Other Drug Abuse or Dependence Treatment
,
Controlling High Blood Pressure
,
Colorectal Cancer Screening
,
Screening for Depression and Follow-Up Plan
,
Follow-Up after Hospitalization for Mental Illness
,
Plan All-Cause Readmissions
,
Use of Pharmacotherapy for Opioid Use Disorder
,
Follow-Up after Emergency Department for Alcohol and Other Drug Abuse or Dependence
,
Follow-Up After Emergency Department Visit for Mental Illness: Age 6 and Older
,
Prevention Quality Indicator (PHI) 92: Chronic Conditions Composite
,
Admission to an Institution from the Community
,
Ambulatory Care: Emergency Department (ED) Visits
,
Inpatient Utilization
,
Common Questions
[Medicaid] GenIC #47 (non-Substantive Change): Health Home Core Sets
[Medicaid] GenIC #82 (New): Quality Improvement Affinity Group Expression of Interest Form
GenIC #82
Universal Expression of Interest (EOI) for Participation
ICR Summary of Burden
Total Approved
Previously Approved
Change Due to New Statute
Change Due to Agency Discretion
Change Due to Adjustment in Estimate
Change Due to Potential Violation of the PRA
Annual Number of Responses
1,029
716
0
313
0
0
Annual Time Burden (Hours)
221,839
96,844
0
124,995
0
0
Annual Cost Burden (Dollars)
0
0
0
0
0
0
Burden increases because of Program Change due to Agency Discretion:
Yes
Burden Increase Due to:
Miscellaneous Actions
Burden decreases because of Program Change due to Agency Discretion:
No
Burden Reduction Due to:
Short Statement:
In this 2024 iteration we propose to increase our burden ceiling from 96,844 to 221,839 hours. The increase is needed to make room for burden associated with our August 31, 2023 (88 FR 60278) final rule (CMS–2440–F; RIN 0938–AU52) which scored 104,395 hours of burden. Since this exceeded our active ceiling of 96,844 and our available ceiling of 76,132 hours the rule’s collection of information requests under GenICs #26 and #47 were not submitted to OMB. Revisions to GenICs #26 and #47 will be submitted to OMB soon after this request to increase the burden ceiling has been approved by OMB.
Annual Cost to Federal Government:
$16,679,945
Does this IC contain surveys, censuses, or employ statistical methods?
No
Does this ICR request any personally identifiable information (see
OMB Circular No. A-130
for an explanation of this term)? Please consult with your agency's privacy program when making this determination.
No
Does this ICR include a form that requires a Privacy Act Statement (see
5 U.S.C. §552a(e)(3)
)? Please consult with your agency's privacy program when making this determination.
No
Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]?
Yes
Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]?
No
Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)?
No
Is this ICR related to the Pandemic Response?
No
Agency Contact:
Mitch Bryman 410 786-5258 Mitch.Bryman@cms.hhs.gov
Common Form ICR:
No
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(a) It is necessary for the proper performance of agency functions;
(b) It avoids unnecessary duplication;
(c) It reduces burden on small entities;
(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;
(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;
(f) It indicates the retention periods for recordkeeping requirements;
(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.
(i) It uses effective and efficient statistical survey methodology (if applicable); and
(j) It makes appropriate use of information technology.
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
Certification Date:
05/02/2024
Something went wrong when downloading this file. If you have any questions, please send an email to risc@gsa.gov.